3M Pharmaceuticals Aldara (Imiquimod) Cream, 5% Included In Multiple Poster Presentations At American Academy Of Dermatology's ACADEMY 06 Meeting
Published: Jul 27, 2006
ST. PAUL, Minn.--(BUSINESS WIRE)--July 27, 2006--3M announced today that Aldara Cream is a featured topic in multiple presentations by leading researchers at the American Academy of Dermatology's (AAD) ACADEMY 06 meeting in San Diego, July 26-30. Aldara Cream is the first and only immune response modifier indicated for the treatment of precancerous actinic keratosis, superficial basal cell carcinoma and external genital and perianal warts. The prescription therapy works by stimulating the skin's immune response to clear diseased or damaged cells.